Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy / 南方医科大学学报
Journal of Southern Medical University
; (12): 1052-1055, 2007.
Article
in Zh
| WPRIM
| ID: wpr-337327
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To study the therapeutic effect of traditional Chinese herbal medicinal preparation Tangshenqing (TSQ) combined with alprostadil in the treatment of early- and intermediate-stage diabetic nephropathy (DN).</p><p><b>METHODS</b>One hundred and twenty DN patients were randomized into 3 groups for different treatment protocols. The patients in the control group were given the basic treatment (low-protein diabetic diet and rigorous control of blood glucose, blood pressure, and blood fatty acid), and those in treatment group A received TSQ (containing Astragalus membranaceus, Panax notoginseng, Epimedium brevicornum, etc) in addition to the basic treatment, and those in treatment group B were treated with alprostadil injections (for 14 consecutive days) in addition to the treatment given in group A. Therapeutic effect evaluation was carried out after a 30-day treatment in all the patients.</p><p><b>RESULTS</b>The overall efficaey rate of the treatment was 78.37% in the control group, 88.57% in the treatment group A, and 94.44% in treatment group B, suggesting better therapeutic effect in the latter two groups than in the control group (P<0.05). Patients in all the 3 groups exhibited symptomatic improvement of various degrees, but the treatment group B had the best results. After the treatments, the patients' blood glucose and fatty acids were lowered, without obvious difference between the 3 groups. Compared with the control group, the patients in the two treatment groups showed significant reduction in fibrinogen, 24-h urine microprotein and urine protein after the treatment (P<0.01 or 0.05).</p><p><b>CONCLUSION</b>Combined use of traditional Chinese herbal medicine TSQ and alprostadil injections produces definite therapeutic effect on early- to intermediate-stage DN.</p>
Full text:
1
Database:
WPRIM
Main subject:
Therapeutics
/
Time Factors
/
Blood Glucose
/
Fibrinogen
/
Treatment Outcome
/
Diabetic Nephropathies
/
Albuminuria
/
Drug Therapy
/
Integrative Medicine
/
Kidney
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
Zh
Journal:
Journal of Southern Medical University
Year:
2007
Document type:
Article